Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™,  A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
12 nov. 2024 08h00 HE | Acuitive Technologies
Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.